Hoffmann AL, Milman N, Byg KE. Childhood sarcoidosis in Denmark 1979–1994: incidence, clinical features and laboratory results at presentation in 48 children. Acta Paediatr. 2004;93(1):30-36.
Ungprasert P, Carmona EM, Utz JP, et al. Epidemiology of sarcoidosis 1946–2013. Mayo Clin Proc. 2016;91(2):183-188.
Yoon HY, Kim HM, Kim YJ, et al. Prevalence and incidence of sarcoidosis in Korea. Respir Res. 2018;19(1):158.
Arkema EV, Grunewald J, Kullberg S, et al. Sarcoidosis incidence and prevalence. Eur Respir J. 2016;48(6):1690-1699.
Baughman RP, Field S, Costabel U, et al. Sarcoidosis in America. Analysis based on health care use. Ann Am Thorac Soc. 2016;13(8):1244-1252.
Dumas O, Abramovitz L, Wiley AS, et al. Epidemiology of sarcoidosis in a prospective cohort study of U.S. women. Ann Am Thorac Soc. 2016;13(1):67-71.
Park JE, Kim YS, Kang MJ, et al. Prevalence, incidence, and mortality of sarcoidosis in Korea, 2003–2015. Respir Med. 2018;144S:S28-S34.
Sikjær MG, Hilberg O, Ibsen R, et al. Sarcoidosis: a nationwide registry-based study of incidence, prevalence and diagnostic work-up. Respir Med. 2021;187:106548.
Arkema EV, Cozier YC. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med. 2020;26(5):527-534.
Terwiel M, van Moorsel CHM. Clinical epidemiology of familial sarcoidosis: a systematic literature review. Respir Med. 2019;149:36-41.
Newman LS, Rose CS, Bresnitz EA, et al.; ACCESS Research Group. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170(12):1324-1330.
Esteves T, Aparicio G, Garcia-Patos V. Is there any association between sarcoidosis and infectious agents?. BMC Pulm Med. 2016;16(1):165.
Inaoka PT, Shono M, Kamada M, et al. Host-microbe interactions in the pathogenesis and clinical course of sarcoidosis. J Biomed Sci. 2019;26(1):45.
Casal A, Suárez-Antelo J, Soto-Feijóo R, et al. Sarcoidosis. Disease progression based on radiological and functional course: predictive fac tors. Heart Lung. 2022;56:62-69.
Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and Other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16(2):149-173.
Kearney GD, Obi ON, Maddipati V, et al. Sarcoidosis deaths in the United States: 1999–2016. Respir Med. 2019;149:30-35.
Kirkil G, Lower EE, Baughman RP. Predictors of mortality in pulmonary sarcoidosis. Chest. 2018;153(1):105-113.
Hena KM. Sarcoidosis epidemiology: race matters. Front Immunol. 2020;11:537382.
Soto-Gomez N, Peters JI, Nambiar AM. Diagnosis and management of sarcoidosis. Am Fam Physician. 2016;93(10):840-848.
Chen ES, Moller DR. Sarcoidosis—scientific progress and clinical challenges. Nat Rev Rheumatol. 2011;7(8):457-467.
Govender P, Berman JS. The diagnosis of sarcoidosis. Clin Chest Med. 2015;36(4):585-602.
Crouser ED, Maier LA, Wilson KC, et al. Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(8):e26-e51.
Carmona EM, Kalra S, Ryu JH. Pulmonary sarcoidosis: diagnosis and treatment. Mayo Clin Proc. 2016;91(7):946-954.
Gupta R, Patel M, Caceres L, et al. Sarcoidosis: an FP’s primer on an enigmatic disease. J Fam Pract. 2021;70(3):E4-E15.
Drent M, Crouser ED, Grunewald J. Challenges of sarcoidosis and its management. N Engl J Med. 2021;385(11):1018-1032.
Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160(2):736-755.
Belperio JA, Shaikh F, Abtin FG, et al. Diagnosis and treatment of pulmonary sarcoidosis: a review. JAMA. 2022;327(9):856-867.
Donovan PJ, Sundac L, Pretorius CJ, et al. Calcitriol-mediated hyper-calcemia: causes and course in 101 patients. J Clin Endocrinol Metab. 2013;98(10):4023-4029.
Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86(4):1343-1346.
Shorr AF, Torrington KG, Parker JM. Serum angiotensin converting enzyme does not correlate with radiographic stage at initial diagnosis of sarcoidosis. Respir Med. 1997;91(7):399-401.
Studdy PR, Lapworth R, Bird R. Angiotensin-converting enzyme and its clinical significance—a review. J Clin Pathol. 1983;36(8):938-947.
Miller BH, Putman CE. The chest radiograph and sarcoidosis. Reevaluation of the chest radiograph in assessing activity of sarcoidosis: a preliminary communication. Sarcoidosis. 1985;2(2):85-90.
Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years’ observation. Br Med J. 1961;2(5261):1165-1172.
Thillai M, Atkins CP, Crawshaw A, et al. BTS clinical statement on pulmonary sarcoidosis [published correction appears in Thorax. 2021; 76(7): e4]. Thorax. 2021;76(1):4-20.
Elgart ML. Cutaneous sarcoidosis: definitions and types of lesions. Clin Dermatol. 1986;4(4):35-45.
Plit ML, Havryk AP, Hodgson A, et al. Rapid cytological analysis of endobronchial ultrasound-guided aspirates in sarcoidosis. Eur Respir J. 2013;42(5):1302-1308.
Masri SC, Bellumkonda L. Sarcoid heart disease: an update on diagnosis and management. Curr Cardiol Rep. 2020;22(12):177.
Stern BJ, Royal W, Gelfand JM, et al. Definition and consensus diagnostic criteria for neurosarcoidosis: from the Neurosarcoidosis Consortium Consensus Group. JAMA Neurol. 2018;75(12):1546-1553.
Acharya NR, Browne EN, Rao N, et al.; International Ocular Sarcoidosis Working Group. Distinguishing features of ocular sarcoidosis in an international cohort of uveitis patients. Ophthalmology. 2018;125(1):119-126.
Chauhan P, Meena D, Hazarika N. Dermoscopy of sarcoidosis: a useful clue to diagnosis. Indian Dermatol Online J. 2018;9(1):80-81.
Khachemoune A. Papules and plaques on the nose. Lupus pernio. Am Fam Physician. 2006;73(8):1431-1432.
Judson MA. The clinical features of sarcoidosis: a comprehensive review. Clin Rev Allergy Immunol. 2015;49(1):63-78.
Baughman RP, Valeyre D, Korsten P, et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. 2021;58(6):2004079.
Paramothayan NS, Lasserson TJ, Jones PW. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev. 2005(2):CD001114.
Grutters JC, van den Bosch JMM. Corticosteroid treatment in sarcoidosis. Eur Respir J. 2006;28(3):627-636.
Rahaghi FF, Baughman RP, Saketkoo LA, et al. Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis. Eur Respir Rev. 2020;29(155):190146.
Paramothayan S, Lasserson TJ, Walters EH. Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis. Cochrane Database Syst Rev. 2006(3):CD003536.
Adler BL, Wang CJ, Bui TL, et al. Anti-tumor necrosis factor agents in sarcoidosis. Semin Arthritis Rheum. 2019;48(6):1093-1104.
Rezaee M, Zangiabadian M, Soheili A, et al. Role of anti-tumor necrosis factor-alpha agents in treatment of sarcoidosis: a meta-analysis. Eur J Intern Med. 2023;109:42-49.
Leard LE, Holm AM, Valapour M, et al. Consensus document for the selection of lung transplant candidates: an update from the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2021;40(11):1349-1379.
Weill D, Benden C, Corris PA, et al. A consensus document for the selection of lung transplant candidates: 2014—an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2015;34(1):1-15.
Bradley B, Branley HM, Egan JJ, et al.; British Thoracic Society Interstitial Lung Disease Guideline Group, British Thoracic Society Standards of Care Committee; Thoracic Society of Australia; New Zealand Thoracic Society; Irish Thoracic Society. Interstitial lung disease guideline [published correction appears in Thorax. 2008; 63(11): 1029]. Thorax. 2008;63(suppl 5):v1-v58.
Spagnolo P, Rossi G, Trisolini R, et al. Pulmonary sarcoidosis. Lancet Respir Med. 2018;6(5):389-402.
Banga A, Sahoo D, Lane CR, et al. Disease recurrence and acute cellular rejection episodes during the first year after lung transplantation among patients with sarcoidosis. Transplantation. 2015;99(9):1940-1945.
Taimeh Z, Hertz MI, Shumway S, et al. Lung transplantation for pulmonary sarcoidosis. Twenty-five years of experience in the USA. Thorax. 2016;71(4):378-379.
Salamo O, Roghaee S, Schweitzer MD, et al. White donor, younger donor and double lung transplant are associated with better survival in sarcoidosis patients. Sci Rep. 2018;8(1):6968.
Hamzeh N, Steckman DA, Sauer WH, et al. Pathophysiology and clinical management of cardiac sarcoidosis. Nat Rev Cardiol. 2015;12(5):278-288.
Kusano KF, Satomi K. Diagnosis and treatment of cardiac sarcoidosis. Heart. 2016;102(3):184-190.
Sadek MM, Yung D, Birnie DH, et al. Corticosteroid therapy for cardiac sarcoidosis: a systematic review. Can J Cardiol. 2013;29(9):1034-1041.
Yodogawa K, Seino Y, Shiomura R, et al. Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis. J Cardiol. 2013;62(5):320-325.
Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1305-1323.
Willner JM, Viles-Gonzalez JF, Coffey JO, et al. Catheter ablation of atrial arrhythmias in cardiac sarcoidosis. J Cardiovasc Electrophysiol. 2014;25(9):958-963.
Akashi H, Kato TS, Takayama H, et al. Outcome of patients with cardiac sarcoidosis undergoing cardiac transplantation—single-center retrospective analysis. J Cardiol. 2012;60(5):407-410.
Lower EE, Baughman RP. The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci. 1990;299(3):153-157.
Pereira J, Anderson NE, McAuley D, et al. Medically refractory neurosarcoidosis treated with infliximab. Intern Med J. 2011;41(4):354-357.
Gelfand JM, Bradshaw MJ, Stern BJ, et al. Infliximab for the treatment of CNS sarcoidosis. Neurology. 2017;89(20):2092-2100.
Fritz D, Timmermans WMC, van Laar JAM, et al. Infliximab treatment in pathology-confirmed neurosarcoidosis. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e847.
Hamada H, Hayashi N, Kurimoto M, et al. Isolated third and fourth ventricles associated with neurosarcoidosis successfully treated by neuroendoscopy—case report. Neurol Med Chir (Tokyo). 2004;44(8):435-437.
Menninger MD, Amdur RJ, Marcus RB. Role of radiotherapy in the treatment of neurosarcoidosis. Am J Clin Oncol. 2003;26(4):e115-e118.
Drake WP, Oswald-Richter K, Richmond BW, et al. Oral antimycobacterial therapy in chronic cutaneous sarcoidosis. JAMA Dermatol. 2013;149(9):1040-1049.
Khatri KA, Chotzen VA, Burrall BA. Lupus pernio: successful treatment with a potent topical corticosteroid. Arch Dermatol. 1995;131(5):617-618.
Wise RD. Clinical resolution of facial cutaneous sarcoidosis with systemic colchicine and a topical corticosteroid ointment. Compr Ther. 2008;34(2):105-110.
Volden G. Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing. Acta Derm Venereol. 1992;72(1):69-71.
Bersani TA, Nichols CW. Intralesional triamcinolone for cutaneous palpebral sarcoidosis. Am J Ophthalmol. 1985;99(5):561-562.
Callen JP. Intralesional corticosteroids. J Am Acad Dermatol. 1981;4(2):149-151.
Wanat KA, Rosenbach M. A practical approach to cutaneous sarcoidosis. Am J Clin Dermatol. 2014;15(4):283-297.
Fazzi P, Manni E, Cristofani R, et al. Thalidomide for improving cutaneous and pulmonary sarcoidosis in patients resistant or with contraindications to corticosteroids. Biomed Pharmacother. 2012;66(4):300-307.
Heidelberger V, Ingen-Housz-Oro S, Marquet A, et al. Efficacy and tolerance of anti-tumor necrosis factor α agents in cutaneous sarcoidosis: a French study of 46 cases [published correction appears in JAMA Dermatol. 2017; 153(8): 837]. JAMA Dermatol. 2017;153(7):681-685.
Lower EE, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med. 1995;155(8):846-851.
Marchetti M, Baker MG, Noland MMB. Treatment of subcutaneous sarcoidosis with hydroxychloroquine: report of 2 cases. Dermatol Online J. 2014;20(1):21250.
Damsky W, Thakral D, McGeary MK, et al. Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare. J Am Acad Dermatol. 2020;82(3):612-621.
Wu JJ, Schiff KR. Sarcoidosis. Am Fam Physician. 2004;70(2):312-322.
Belfer MH, Stevens RW. Sarcoidosis: a primary care review. Am Fam Physician. 1998;58(9):2041-2050.